InsidersTradesSigma
Track the GENETIC SIGNATURES LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the authority of ASX. The latest transaction was disclosed on 1 July 2026 (Cease Substantial Holding). Among the most active insiders: Unknown Substantial Holder. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
GENETIC SIGNATURES LIMITED is a company listed on the Australian Securities Exchange, specializing in the development of diagnostic tests based on DNA technology. It focuses on solutions for the detection of infectious diseases.